project id: TCGA-STAD; case submitter id: TCGA-ZA-A8F6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.35; rna integrity number: 7.2; age at index: 71; days to birth: -26122; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 26122; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 525.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8144/3; primary diagnosis: Adenocarcinoma, intestinal type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 35; days to sample procurement: 0; initial weight: 410.0; portion submitter id: TCGA-ZA-A8F6-01A-23; percent lymphocyte infiltration: 14.0; percent monocyte infiltration: 2.0; percent necrosis: 3.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 47.0; percent tumor nuclei: 80.0;